catalyst

Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2011-08-10 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia — primary completion
Type
Trial Readout
Date
2011-08-10
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here
trial
Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia
trial